ËÄÉ«AV

This is the first session of aÌýthree-part webinar series on Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management.

Ìý

Watch On-demand.

Gated content. Registration is required.

Ìý

Ìý

Learn more about this webinar series here.

Ìý

Featured ËÄÉ«AV experts in this webinar
Senior Analytical ScientistÌý R&D, Analytical Development	ScientistÌý R&D Oral Drug Product - Formulation Group	ScientistÌý R&D Oral Drug Product - Formulation Group​​​​

Ìý

, , and kick-off the series by focusing on the role of amorphous solid dispersions in modern oral drugs and how the right formulation for a drug candidate can be selected using ËÄÉ«AV’s proprietary screening methodology. This method is performed via an automated high-throughput system that was developed over many years of experience with formulation of ASDs. The speakers will provide an understanding of the methodology, the evaluation process, and the studies typically utilized, as well as key information needed to make a formal assessment of the best candidates.

Ìý

Your Key Learning Objectives

• Understand the increasing importance of amorphous solid dispersions in oral drug delivery of new chemical entities
• Get an overview of ËÄÉ«AV’s methodology to screen the best formulations in amorphous solid dispersions for a given API candidate
• Learn about the formulation criteria based on stability, performance, and manufacturability data

Ìý

Who Should AttendÌý
This webinar is suitable for anyone working in formulation of oral drugs, procurement, and outsourcing teams or as a project manager, who is interested in understanding the whole assessment process and their role in it.

Watch On-demand.

Gated content. Registration is required.

Do you have a challenging projectÌýneeding differentiating technologies and an innovative approach?

Ìý